IndiDX

Boulder, United States Founded: 2005 • Age: 21 yrs Acquired By Biodesix
Blood-based diagnostics for oncology.
Request Access

About IndiDX

IndiDX is a company based in Boulder (United States) founded in 2005 was acquired by Biodesix in July 2018.. IndiDX has raised $82.81 million across 6 funding rounds from investors including Biodesix, Baird Capital and InterWest. The company has 17 employees as of December 31, 2017. IndiDX operates in a competitive market with competitors including Oncimmune, Biodesix, Broncus, OncoCyte and Riverain Tech, among others.

  • Headquarter Boulder, United States
  • Employees 17 as on 31 Dec, 2017
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Integrated Diagnostics Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $82.81 M (USD)

    in 6 rounds

  • Latest Funding Round
    $6.1 M (USD), Series C

    Dec 08, 2016

  • Investors
    Biodesix

    & 6 more

  • Employee Count
    17

    as on Dec 31, 2017

  • Acquired by
    Biodesix

    (Jul 09, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of IndiDX

IndiDX has successfully raised a total of $82.81M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $6.1 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series C — $6.1M
  • First Round

    (01 Jun 2005)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2016 Amount Series C - IndiDX Valuation Baird Capital , InterWest Partners
May, 2014 Amount Series B - IndiDX Valuation Baird Capital , Wellcome Trust
Apr, 2014 Amount Debt – Conventional - IndiDX Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in IndiDX

IndiDX has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Biodesix, Baird Capital and InterWest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Global private equity and venture capital investments in B2B Tech & Services companies.
Founded Year Domain Location
Early-stage investing in IT and healthcare ventures.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by IndiDX

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - IndiDX

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Indidx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of IndiDX

IndiDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oncimmune, Biodesix, Broncus, OncoCyte and Riverain Tech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Diagnostics and risk assessment solutions for lung cancer are developed.
domain founded_year HQ Location
Cancer detection diagnostics assays are developed and offered.
domain founded_year HQ Location
Minimally invasive technologies for lung disease treatment are developed.
domain founded_year HQ Location
Non-invasive diagnostic test solutions for cancer treatment are developed.
domain founded_year HQ Location
Software tools are developed for early lung disease detection.
domain founded_year HQ Location
Developer of diagnostic product for colon cancer
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Indidx

Frequently Asked Questions about IndiDX

When was IndiDX founded?

IndiDX was founded in 2005.

Where is IndiDX located?

IndiDX is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.

Is IndiDX a funded company?

IndiDX is a funded company, having raised a total of $82.81M across 6 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $17M, raised on Jun 01, 2005.

How many employees does IndiDX have?

As of Dec 31, 2017, the latest employee count at IndiDX is 17.

What does IndiDX do?

Integrated Diagnostics (Indi) is developing blood based diagnostics for oncology by following a systems biology based approach. Its flagship product, the Xpresys Lung test claims to detect the molecular changes in proteins associated with the presence of lung cancer and provide a non-invasive assessment of pulmonary nodules. Patient blood is analyzed by mass spectrometry that provides specific detection of target proteins. When combined with clinical assessment, Xpresys Lung claims to be able to help reduce unnecessary invasive procedures.

Who are the top competitors of IndiDX?

IndiDX's top competitors include Biodesix, OncoCyte and ONCOHOST.

Who are IndiDX's investors?

IndiDX has 7 investors. Key investors include Biodesix, Baird Capital, InterWest, Wellcome, and Life Sciences Alternative Funding.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available